2 completed. 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow bactericidal permeability increasing protein: new trials by email Literature Review of bactericidal permeability increasing protein trials Research Report on bactericidal permeability increasing protein
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children General and Neurological examination, Vital signs, 12 lead electrocardiogram - Quality of Life, Renal Insufficiency | Not applicable | Completed | Baylor Research Institute | 5 | 2018-11-10 | 2026-03-04 |
| A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure Darunavir, Etravirine, Emtricitabine/tenofovir disoproxil fumarate - HIV-1 Infection | Phase 4 | Completed | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 545 | 2013-02-22 | 2019-03-15 |
Cardiovascular Diseases (1) · Renal Insufficiency (1)
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1) · Baylor Research Institute (1)
Brazil (1) · Haiti (1) · India (1) · Kenya (1) · Malawi (1) · Peru (1) · South Africa (1) · Thailand (1) · Uganda (1) · United States (1) · Zimbabwe (1)
Beatriz Grinsztejn, MD, PhD (1) · Peter Mugyenyi, MB ChB, FRCP, DSc (1)
PMID 31371262, PMID 31528850, PMID 32049773, PMID 36039892
U01AI068636 (1)